Medicinal Chemistry of Nanoparticles for Cancer Theranostics

Authors

  • Sandip Zine Pharmaceutical Chemistry, Vivekanand Education Society's College of Pharmacy, Chembur, Mumbai, Maharashtra, India
  • Sarita Kunchikorve
  • Pooja Dubey

Abstract

Cancer is a disease in which cells growth is uncontrollable and conventional treatment have a few side effects, for example, nonspecific delivery, unable to enter the center of tumor and absence of solubility. Nanoparticles could directly target disease cells specifically and increased medication localization in tumor cells giving exact cellular uptake. The theranostic nanomedicine can accomplish systemic flow, avoid host resistances and deliver the medication and diagnostic agents at the target site to analyze and treat the tumor at cellular and molecular level; in short it is a combination of therapeutic and diagnostic agent. Gold nanoparticles, quantum dots are used as nanotheranostics. These agents act by passive and active targeting on cancerous cells. Synthesis of nanotheranostic is also discussed.

 

Keywords: Cancer, Nanotheranostics, Quantum dots, Gold nanoparticle

Cite this Article

Sandip Zine, Sarita Kunchikorve, Pooja Dubey. Medicinal Chemistry of Nanoparticles for Cancer Theranostics. Research & Reviews: A Journal of Drug Design & Discovery. 2016; 3(3):       28–41p.

Downloads

Published

2019-03-04

Issue

Vol. 3 No. 3 (2016)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.